CRISPR Therapeutics (CRSP) PT Raised to $64 at Barclays
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $53.55 -0.81%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Gena Wang raised the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $64.00 (from $61.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
